Eikon Therapeutics, Inc. (EIKN)
11.90
+0.66
(+5.87%)
USD |
NASDAQ |
Apr 17, 16:00
11.82
-0.08
(-0.67%)
After-Hours: 20:00
Eikon Therapeutics Enterprise Value : 1.725B for April 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Veradermics, Inc. | 2.973B |
| The Cigna Group | 105.09B |
| Bristol Myers Squibb Co. | 159.03B |
| Gossamer Bio, Inc. | 170.65M |
| Generate Biomedicines, Inc. | -- |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -79.66M |
| Total Expenses (Quarterly) | 79.66M |
| EPS Diluted (Quarterly) | -1.471 |
| Earnings Yield | -12.36% |